Jove
Visualize
Contact Us

Related Experiment Videos

Aluminum accumulation in individuals with normal renal function.

S M Ott

    American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
    |November 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
    Same author

    Sensitivity and specificity of radiographic characteristics in atypical femoral fractures.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
    Same author

    Utility of automated data in identifying femoral shaft and subtrochanteric (diaphyseal) fractures.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2010
    Same author

    Bisphosphonates and BMU birth rate.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2009
    Same author

    Effects of three years of low-dose thiazides on mineral metabolism in healthy elderly persons.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2008
    Same author

    Association between caffeine intake and bone mass among young women: potential effect modification by depot medroxyprogesterone acetate use.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2007
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Parenteral aluminum administration can cause bone disease, even in people with healthy kidneys. This accumulation leads to lesions and low calcitriol and parathyroid hormone (PTH) levels, confirming aluminum

    Area of Science:

    • Nephrology
    • Bone Metabolism
    • Toxicology

    Background:

    • Aluminum is generally excreted by healthy kidneys when taken orally.
    • Parenteral administration bypasses renal excretion, leading to potential accumulation.

    Purpose of the Study:

    • To investigate the effects of parenteral aluminum administration on bone health in individuals with normal renal function.
    • To determine if aluminum toxicity to bone occurs despite adequate kidney function.

    Main Methods:

    • Review of existing literature on aluminum absorption, excretion, and toxicity.
    • Analysis of case studies involving parenteral aluminum exposure in patients with normal renal function.

    Main Results:

    • Parenteral aluminum accumulates in tissues, causing osteomalacia and aplastic bone lesions.

    Related Experiment Videos

  • Reduced calcitriol and parathyroid hormone (PTH) levels are frequently observed.
  • These effects occur even when renal function is normal.
  • Conclusions:

    • Aluminum is toxic to bone, irrespective of renal function, when administered parenterally.
    • Accumulated aluminum and associated hormonal changes contribute to bone pathology.